Eon T.

Director, Payer Evidence, Methods, & Access Affairs @AstraZeneca

Toronto, ON, CA
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2024 — Present

Director, Payer Evidence, Methods, & Access Affairs @AstraZeneca

View department →

Toronto, ON, CA

Overseeing the AZ Canada strategic approach to health economics, payer evidence, and access policy, with focus on better interpreting evidence, improving HTA efficiency, enhancing product valuations, and expediting patient access.• Advancing the field of HTA in Canada and internationally through the development of payer evidence on endpoint surrogacy, adoption of AI in HTA, patient preference modelling, and data transportability• Prioritizing external appointments to support HTAi, ISPOR, and CAPT, as well as fostering meaningful partnerships with key payer/HTA experts, academics, clinicians, and patient advocates with the aim to improve Canadian public reimbursement processes and policies.• Created entirely new team structure, vision, roles, and responsibilities of a best-in-class technical team developing optimal health economic valuations.

EDUCATION

2011 — 2015

University of Toronto

Master of Science (MSc), International HTA, Health Policy & Management

2008 — 2010

The University of British Columbia

Master of Business Administration (MBA), Strategic Management, Marketing

1999 — 2003

The University of British Columbia

Bachelor of Science (BSc), Biochemistry and Chemistry Honours

SKILLS

Product LaunchBrand DevelopmentHealth EconomicsHtaPharmaceuticalsMarketing StrategyDiabetesSales EffectivenessCrmInfluenzaVaccinesCardiologyHospital SalesBudgetsMarket AnalysisPsychiatryProject ManagementStrategic PlanningGastroenterologyBusiness AlliancesMarket InsightsMarket ResearchHealth Technology AssessmentAlliance MarketingPharmaceutical IndustryHealthcareOncologySalesMental HealthBiotechnology

ABOUT EON T.

Let\'s work together and make sure that patients have access to the most innovative medicines and the best health technologies possible. I believe that through our collaboration and ingenuity, we can make this happen in Canada and act as a leader in healthcare globally.Special interests and experience: HTA, evidence interpretation, artificial intelligence (AI), patient access, pharmaceutical and health technology innovation, new product launch, brand strategy, cross-functional team leadership, people development, P&L management

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Eon T. — Director, Payer Evidence, Methods, & Access Affairs at AstraZeneca in Toronto, ON, CA | Unifers